{"a":[{"_":"Definium LSD drug goes 3 for 3 with another pivotal anxiety trial win","$":{"href":"/biotech/definium-lsd-drug-goes-3-3-another-pivotal-anxiety-trial-win","hreflang":"en"}}]}
Phase 3positiveLSDPositive
AI Analysis
Summary
Definium Therapeutics announced a third consecutive phase 3 trial win for its LSD-based therapeutic, demonstrating significant anxiety symptom alleviation and paving the way for an FDA filing later in 2026.
Clinical Trial Data
Phase
3
Primary Endpoint
Met
Outcome Details
Third consecutive phase 3 win with significant alleviation of anxiety symptoms
Importance:8/10
Sentiment:
0.85
phase 3LSDpsychedelicanxietyclinical trialpositive dataFDA filing
Read the original article
Published by FierceBiotech on September 11, 2026 3:07 PM